Generate Biomedicines, Inc.
Ticker: 2100782
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 6.31-12.6% | 7.22-28.7% | 10.13+14.9% | 8.82 |
| Total Income | 6.31-12.6% | 7.22-28.7% | 10.13+14.9% | 8.82 |
| EXPENSES | ||||
| Expenditure | 77.93+9.2% | 71.34+1.5% | 70.28+23.4% | 56.97 |
| Tax | 0.05+66.7% | 0.03-25.0% | 0.04-33.3% | 0.06 |
| PROFIT | ||||
| PBT | -67.20-8.9% | -61.69-8.8% | -56.70-28.1% | -44.26 |
| Net Profit | -67.26-9.5% | -61.45-17.2% | -52.43-25.8% | -41.69 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.52+51.4% | -1.07+44.8% | -1.94-19.8% | -1.62 |